Cocoon Biotech, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cocoon Biotech, Inc. - overview
Established
2013
Location
-, MA, US
Primary Industry
Biotechnology
About
Founded in 2013 and based in Massachusetts, US, Cocoon Biotech, Inc. operates as a sustainable technology company specializing in the use of silk fibroin to create environmentally friendly and safe products for healthcare, consumer, and industrial applications. The company was founded by its CEO, Ailis Tweed-Kent. The company's core product, silk fibroin, is a biodegradable protein derived from silkworm cocoons.
It offers an alternative to petroleum-derived ingredients commonly used in various products. Cocoon™ utilizes this silk fibroin to formulate a wide range of all-natural personal care products, including sunscreen, moisturizing lotion, anti-aging serum, insect repellent, and hand sanitizer. In addition to consumer products, silk fibroin is also used in pharmaceutical and medical device formulations, enhancing cell proliferation, and promoting healing. Cocoon™ has engineered an adaptable and sustainable natural material, combining expertise in biotechnology, medicine, materials science, and green product design.
Current Investors
Argonautic Ventures
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.cocoonbiotech.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.